Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Biological Chemistry
Arbor Biotechnologies, a genome-mining start-up that launched in 2016 and raised $15.6 million in series A funding last June, is stepping out of stealth mode with a publication detailing the discovery of a CRISPR gene-editing system—an enzyme called Cas13d—that could be used to edit RNA instead of DNA (Molecular Cell 2018, DOI: 10.1016/j.molcel.2018.02.028). The start-up will use artificial intelligence to scour genomes for useful peptides, proteins, and enzymes. Broad Institute’s Feng Zhang, one inventor of CRISPR gene editing, is among the company’s founders.
This article has been sent to the following recipient: